Skip to main content
Equibles

Occam Crest Management LP

Position in AXSM — Axsome Therapeutics, Inc.

CIK 2085909 Darien, CT
Back to AXSM Full portfolio

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,294,146
+$1,443,688 QoQ
Shares Held
29,800
-13.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
3.64%
of 13F equity value
Holder Rank
#141
of 504 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Occam Crest Management LP holds $59,155,147 across 5 Biotechnology names. AXSM ranks #3 (12.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TGTX
Tg Therapeutics, Inc.
 425,000 $23,349,500
2 PGEN
Precigen, Inc.
 3,605,941 $20,553,863
3 AXSM
Axsome Therapeutics, Inc.
This page 		29,800 $7,294,146
4 NVCT
Nuvectis Pharma, Inc.
 357,147 $6,567,933
5 IMRX
Immuneering Corp
 278,498 $1,389,705

All Filings in AXSM

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,294,146 29,800
2026-03-31 $5,850,458 34,614
2025-12-31 $6,392,400 35,000
2025-09-30 $4,007,850 33,000